Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company ir pasaules farmācijas un veselības aprūpes uzņēmums, kas izstrādā, ražo un izplata recepšu medikamentus. Tā darbība aptver diabēta, vēža, Alcheimera slimības, autoimūno slimību, dermatoloģijas, migrēnas, aptaukošanās un miega apnojas jomas. Uzņēmuma darbu atbalsta klīniskie pētījumi, zāļu drošuma programmas un ražošanas operācijas. Uzņēmums nodrošina arī pacientu izglītošanu, piekļuves resursus, informāciju par klīniskajiem pētījumiem un LillyDirect aptieku pakalpojumus, kā arī pēta tādas jomas kā ģenētiskās zāles.

Senior Director, Global Medical Affairs – Orexin Therapies

Lead global medical strategy for cleminorexton, an orexin therapy for narcolepsy and other sleep-wake disorders. The role guides launch readiness, evidence generation, scientific engagement, and collaboration across medical and commercial teams.

Apraksts

  • Set the global medical affairs strategy and execution plan for cleminorexton.
  • Act as Global Medical Affairs Lead and a core member of the cross-functional asset team.
  • Connect medical strategy with company objectives, clinical development milestones, and commercialization plans.
  • Plan for regulatory approvals, launch readiness, and product lifecycle management.
  • Identify scientific opportunities, evidence gaps, and stakeholder needs.
  • Direct medical launch preparation across key global markets.
  • Build launch plans with commercial, market access, HEOR, regulatory, and regional medical teams.
  • Coordinate scientific platforms, training, medical information, publications, congress activities, and insight gathering with strategy and launch timelines.
  • Contribute to pre-launch and launch planning, including global payer engagement and value communication.
  • Develop relationships with global opinion leaders, investigators, professional societies, and patient advocacy groups.
  • Lead scientific advisory boards, expert consultations, and other insight initiatives.
  • Represent Centessa at major scientific congresses and industry meetings.
  • Serve as a scientific ambassador and expert on orexin biology and sleep-wake disorders.
  • Work with commercial, market access, HEOR, regulatory, clinical development, patient advocacy, and corporate affairs teams.
  • Bring medical expertise to brand strategy, payer engagement, disease education, and scientific communications.
  • Help develop scientific platforms, publication plans, educational programs, and medical training.
  • Review and guide external scientific materials to ensure compliance with regulations and company policies.
  • Report to the Head of Medical Affairs and collaborate with senior leaders.

Prasības

  • Advanced scientific or clinical degree, such as an MD, PharmD, or PhD.
  • At least 10 years of Medical Affairs leadership experience; 5 years of global experience is preferred.
  • Background in neuroscience, sleep medicine, neurology, psychiatry, or rare disease.
  • Experience leading at least one successful global product launch.
  • Experience as a global medical lead for a late-stage development or commercial product.
  • Strong knowledge of global medical affairs, evidence generation, payer evidence needs, and commercialization readiness.
  • Ability to set and drive strategy in a matrix organization.
  • Track record of working across commercial, market access, HEOR, regulatory affairs, and clinical development.
  • Excellent communication, presentation, and stakeholder management skills.
  • Must be based in the United States.
  • Willingness to travel approximately 20% of the time.

Priekšrocības

  • Company bonus based on company and individual performance.
  • Company-sponsored 401(k) plan.
  • Pension plan.
  • Vacation benefits.
  • Medical, dental, vision, and prescription drug coverage.
  • Flexible benefits, including healthcare and/or dependent care flexible spending accounts.
  • Life insurance and death benefits.
  • Time off and leave of absence benefits.
  • Well-being programs, including an employee assistance program, fitness benefits, and employee clubs and activities.
  • Remote work arrangement.
  • Travel opportunities, approximately 20%.